Iovance Biotherapeutics, Inc. - Common Stock — Flux de trésorerie trimestriel (NASDAQ:IOVA)

Afficher le graphique complet Full chart

Financials

Total de l'actif 910.43 M966.74 M907.44 M904.95 M913.17 M925.66 M Total du passif 200.02 M198.88 M208.95 M202.66 M214.59 M203.91 M Total des capitaux propres 710.4 M767.87 M698.49 M702.29 M698.58 M721.75 M Total du passif et des capitaux propres 910.43 M966.74 M907.44 M904.95 M913.17 M925.66 M Dette totale 1 M————— Dette nette -322.78 M—————

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics, Inc. - Common Stock

Nouvelles

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio: Anktiva Explained and What Comes Next

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

La vente à découvert d’Intellia progresse le plus parmi les biotechs

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Undercovered Stocks: Western Digital, SAP, Toast And More

Pacira (PCRX) Q1 Earnings Miss Estimates

Iovance Biotherapeutics (IOVA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Regeneron (REGN) Surpasses Q1 Earnings and Revenue Estimates